The ability to improve diagnosis and refine prognosis in children with
acute leukaemia is improving steadily. A growing number of tests can
and are being performed on leukaemic cells. These include surface-mark
er analysis, DNA content, cytogenetics and studies of gene rearrangeme
nts. Increasingly large bone-marrow samples, now usually obtained unde
r general anaesthesia, are required to make secure diagnoses. Ethical
issues arise from three major areas. 1) Current research on leukaemia
cells requested by the Medical Research Council is considered by local
research ethics committees, but parents are not regularly given detai
led information about or asked specifically to consent to such researc
h; 2) substantial quantities of excess cells are stored indefinitely.
This archive of stored material is a valuable resource for research bu
t there has been little consideration of the ethical issues which aris
e from this practice, and 3) there is a potential for pressure to obta
in increasingly large samples. 'Creeping growth' in sample size is lik
ely to continue unless ethics committees consider future research prop
osals in more derail. These issues deserve attention in order that wor
thwhile research and its publication are not impeded for want of ethic
al consideration. The implications extend beyond the field of childhoo
d leukaemia.